86.5% of SOX2-positive glioma stem-like cells co-expressed VCAM1 in a mouse model. This dataset likely contains tabular data from experiments evaluating VCAM1 expression in human glioma datasets and mouse models, correlating it with survival outcomes. It was authored by Jiajing Dai and last updated on April 24, 2026.
Use Cases
- Correlating VCAM1 expression levels with patient survival outcomes based on clinical data mentioned in the description
- Analyzing VCAM1 enrichment in glioma stem cell-like populations based on co-expression percentages
- Evaluating the impact of astrocytic VCAM1 deletion on tumor growth and mouse survival based on experimental results
Strengths
- Includes specific co-expression percentages (e.g., 93.4% of Ki67+ cells) from mouse models
- Correlates findings with clinical patient survival data
- Data is openly licensed under CC-BY-4.0
Limitations
- Column-level documentation is absent; field semantics must be inferred after download
- Row count is unknown, which may limit suitability assessment
- The 609.9 KB size suggests a limited scope of data
Provenance
- Source
- figshare
- Collection Method
- Likely generated from analysis of human glioma datasets and experiments using syngeneic and primary mouse glioma models.
- Freshness
- Last updated 2026-04-24 04:23:00; freshness should be verified